Highly Active Antiretroviral Therapy Use and HIV Transmission Risk Behaviors Among Individuals Who Are HIV Infected and Were Recently Released from Jail

Overview

Journal Am J Public Health

Specialty Public Health

Date 2008 Mar 1

PMID 18309132

Citations 34

Authors

Kristen Clements-Nolle

Rani Marx

Michael Pendo

Eileen Loughran

Milton Estes

Mitchell Katz

Affiliations

Soon will be listed here.

Abstract

We evaluated highly active anti-retroviral therapy (HAART) use and risk behaviors among 177 inmates who were HIV infected and were released and reincarcerated in San Francisco, Calif, jails over a 12-month period. During the month preceding reincarceration, HIV transmission risk behaviors were common among respondents, and 59% of those with a history of antiretroviral use were not taking HAART. HAART discontinuation was independently associated with homelessness, marijuana use, injection drug use, and not receiving community medical care. Postrelease interventions for inmates who are HIV infected are needed.

Citing Articles

HIV Care Continuum Among People Living With HIV and History of Arrest and Mental Health Diagnosis.

Wiehe S, Nelson T, Aalsma M, Rosenman M, Gharbi S, Fortenberry J J Acquir Immune Defic Syndr. 2023; 94(5):403-411.

PMID: 37949443 PMC: 10642694. DOI: 10.1097/QAI.0000000000003296.

Effect of Yoga on Antiretroviral Adherence Postincarceration in HIV+ Individuals.

Wimberly A, Gross R, Layde M J Correct Health Care. 2020; 26(1):83-94.

PMID: 32089078 PMC: 7733694. DOI: 10.1177/1078345819897924.

How yoga impacts the substance use of people living with HIV who are in reentry from prison or jail: A qualitative study.

Wimberly A Complement Ther Med. 2019; 47:102074.

PMID: 31780010 PMC: 6886577. DOI: 10.1016/j.ctim.2019.03.022.

Life Chaos is Associated with Reduced HIV Testing, Engagement in Care, and ART Adherence Among Cisgender Men and Transgender Women upon Entry into Jail.

Takada S, Ettner S, Harawa N, Garland W, Shoptaw S, Cunningham W AIDS Behav. 2019; 24(2):491-505.

PMID: 31396766 PMC: 6994355. DOI: 10.1007/s10461-019-02570-0.

Criminal Justice System Involvement as a Risk Factor for Detectable Plasma HIV Viral Load in People Who Use Illicit Drugs: A Longitudinal Cohort Study.

Ickowicz S, Mohd Salleh N, Fairbairn N, Richardson L, Small W, Milloy M AIDS Behav. 2019; 23(9):2634-2639.

PMID: 31236749 PMC: 6773261. DOI: 10.1007/s10461-019-02547-z.

References

Springer S, Pesanti E, Hodges J, Macura T, Doros G, Altice F . Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis. 2004; 38(12):1754-60. DOI: 10.1086/421392. View

Richie B, Freudenberg N, Page J . Reintegrating women leaving jail into urban communities: a description of a model program. J Urban Health. 2001; 78(2):290-303. PMC: 3456359. DOI: 10.1093/jurban/78.2.290. View

Weissman M, Sholomskas D, Pottenger M, Prusoff B, Locke B . Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol. 1977; 106(3):203-14. DOI: 10.1093/oxfordjournals.aje.a112455. View

Howard A, Arnsten J, Lo Y, Vlahov D, Rich J, Schuman P . A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS. 2002; 16(16):2175-82. DOI: 10.1097/00002030-200211080-00010. View

Moss A, Hahn J, Perry S, Charlebois E, Guzman D, Clark R . Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. Clin Infect Dis. 2004; 39(8):1190-8. DOI: 10.1086/424008. View

Conklin T, Lincoln T, Flanigan T . A public health model to connect correctional health care with communities. Am J Public Health. 1998; 88(8):1249-50. View

Altice F, Mostashari F, Friedland G . Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2001; 28(1):47-58. DOI: 10.1097/00042560-200109010-00008. View

Grinstead O, Faigeles B, Comfort M, Seal D, Nealey-Moore J, Belcher L . HIV, STD, and hepatitis risk to primary female partners of men being released from prison. Women Health. 2005; 41(2):63-80. DOI: 10.1300/J013v41n02_05. View

Porco T, Martin J, Page-Shafer K, Cheng A, Charlebois E, Grant R . Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS. 2004; 18(1):81-8. PMC: 2442908. DOI: 10.1097/00002030-200401020-00010. View

10.

Glaser J, Greifinger R . Correctional health care: a public health opportunity. Ann Intern Med. 1993; 118(2):139-45. DOI: 10.7326/0003-4819-118-2-199301150-00010. View

11.

CARPENTER C, Cooper D, Fischl M, Gatell J, Gazzard B, Hammer S . Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA. 2000; 283(3):381-90. DOI: 10.1001/jama.283.3.381. View

12.

Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke J, Flanigan T . Human immunodeficiency virus in correctional facilities: a review. Clin Infect Dis. 2002; 35(3):305-12. DOI: 10.1086/341418. View

13.

Ewing J . Detecting alcoholism. The CAGE questionnaire. JAMA. 1984; 252(14):1905-7. DOI: 10.1001/jama.252.14.1905. View

14.

Pulvirenti J, Glowacki R, Muppiddi U, Surapaneni N, Gail C, Kohl B . Hospitalized HIV-infected patients in the HAART era: a view from the inner city. AIDS Patient Care STDS. 2004; 17(11):565-73. DOI: 10.1089/108729103322555953. View

15.

Flanigan T, Rich J, Spaulding A . HIV care among incarcerated persons: a missed opportunity. AIDS. 1999; 13(17):2475-6. DOI: 10.1097/00002030-199912030-00020. View

16.

Rich J, Holmes L, Salas C, Macalino G, Davis D, Ryczek J . Successful linkage of medical care and community services for HIV-positive offenders being released from prison. J Urban Health. 2001; 78(2):279-89. PMC: 3456358. DOI: 10.1093/jurban/78.2.279. View

17.

Kral A, Lorvick J, Ciccarone D, Wenger L, Gee L, Martinez A . HIV prevalence and risk behaviors among men who have sex with men and inject drugs in San Francisco. J Urban Health. 2005; 82(1 Suppl 1):i43-50. PMC: 3456175. DOI: 10.1093/jurban/jti023. View

18.

Musicco M, Lazzarin A, Nicolosi A, Gasparini M, Costigliola P, Arici C . Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission. Arch Intern Med. 1994; 154(17):1971-6. View

19.

Knowlton A, Arnsten J, Eldred L, Wilkinson J, Gourevitch M, Shade S . Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users. J Acquir Immune Defic Syndr. 2006; 41(4):486-92. DOI: 10.1097/01.qai.0000186392.26334.e3. View

20.

Grant R, Hecht F, Warmerdam M, Liu L, Liegler T, Petropoulos C . Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA. 2002; 288(2):181-8. DOI: 10.1001/jama.288.2.181. View